Case number 1:18-cv-00765
Gilead Sciences, Inc. et al v. Aurobindo Pharma Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 10, 2018 | 18 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,642,245 B1 ;US 6,703,396 B1. (Attachments: # (1) Signed Stipulation and Order for Dismissal with Prejudice)(fms) |
| Oct 10, 2018 | 18 | Signed Stipulation and Order for Dismissal with Prejudice (2) |
| Oct 10, 2018 | 18 | Patent/Trademark Report to Commissioner (1) |
| Oct 10, 2018 | 17 | SO ORDERED (2) Docket Text: SO ORDERED, re [16] Stipulation of Dismissal filed by Emory University, Gilead Sciences, Inc., ***Civil Case Terminated. Signed by Judge Colm F. Connolly on 10/9/2018. (fms) |
| Oct 5, 2018 | 16 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal with Prejudice by Emory University, Gilead Sciences, Inc.. (Farnan, Brian) |
| Oct 4, 2018 | 15 | Order Staying Case (1) Docket Text: ORDER STAYING CASE. Within 30 days, the parties will file a stipulation of dismissal of this action or report to the Court on the status of settlement. Signed by Judge Colm F. Connolly on 10/4/2018. (fms) |
| Oct 4, 2018 | N/A | Remark (0) Docket Text: The 10/10/2018 scheduling conference is cancelled per the order staying the case (D.I. [15]). (nmf) |
| Oct 3, 2018 | 14 | Stipulation (1) Docket Text: STIPULATION Staying Case by Emory University, Gilead Sciences, Inc.. (Farnan, Brian) |
| Sep 17, 2018 | 13 | Order Setting Scheduling Conference (1) Docket Text: Order Setting In-Person Patent Scheduling Conference: A Scheduling Conference is set for 10/10/2018 at 02:00 PM in Chambers before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 9/17/2018. (nmf) |
| Sep 14, 2018 | 12 | Status Report (1) Docket Text: STATUS REPORT by Emory University, Gilead Sciences, Inc.. (Farnan, Brian) |
| Sep 12, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER by Judge Colm F. Connolly on 9/12/2018: In light of the reassignment of this case, the Court HEREBY ORDERS that the prior referral to Magistrate Judge Sherry R. Fallon is withdrawn, with the exception that any referral to a Magistrate Judge for ADR shall remain in place. (nmf) |
| Sep 12, 2018 | N/A | SO ORDERED (0) |
| Sep 12, 2018 | 10 | Answer to Complaint (26) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Emory University, Gilead Sciences, Inc. by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd..(Connolly, Arthur) |
| Sep 12, 2018 | 11 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Connolly, Arthur) |
| Sep 10, 2018 | 9 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Answer Complaint to September 12, 2018 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Connolly, Arthur) |
| Sep 7, 2018 | N/A | Oral Order (0) |
| Aug 27, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Aug 10, 2018 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Gilead Sciences, Inc., Emory University. Aurobindo Pharma USA, Inc. served on 8/8/2018, answer due 8/29/2018. (Farnan, Brian) |
| Aug 8, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma USA, Inc. on 8/8/2018. (jcs) |
| May 31, 2018 | N/A | Oral Order (0) |
| May 30, 2018 | N/A | Case Assigned/Reassigned (0) |
| May 30, 2018 | N/A | Case Referred to Magistrate Judge (0) Docket Text: CASE REFERRED to Magistrate Judge Sherry R. Fallon. (rjb) |
| May 18, 2018 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (ceg) |
| May 18, 2018 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Emory University. (ceg) |
| May 18, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc. (ceg) |
| May 18, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,642,245 B1; US 6,703,396 B1. (ceg) |
| May 18, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/5/2018. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 10/5/2020. (ceg) |
| May 18, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| May 18, 2018 | 1 | Civil Cover Sheet (1) |
| May 18, 2018 | 1 | Exhibit B (19) |
| May 18, 2018 | 1 | Exhibit A (27) |
| May 18, 2018 | 1 | Main Document (13) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2384737.) - filed by Gilead Sciences, Inc., Emory University. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Civil Cover Sheet)(ceg) |
| May 18, 2018 | 1 | Complaint (13) |
| May 18, 2018 | 1 | Complaint* (1) |
